COVID-19 | Page 9 | Pathology & Laboratory Medicine

Pathology & Laboratory Medicine

Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.

Hansen G, Marino J, Wang Z-X, Beavis KG, Rodrigo J, Labog K, Westblade LF, Jin R, Love N, Ding K et al.. 2021. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.. J Clin Microbiol. 59(2)

Microthrombosis associated with GI bleeding in COVID-19.

Buckholz A, Kaplan A, Jessurun J, De Jong Y, Crawford C. 2021. Microthrombosis associated with GI bleeding in COVID-19.. Gastrointest Endosc. 93(1):263-264.

Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.

Yantiss RK, Qin L, He B, Crawford CV, Seshan S, Patel S, Wahid N, Jessurun J. 2021. Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease.. Am J Surg Pathol.

Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.

Bushman D, Alroy KA, Greene SK, Keating P, Wahnich A, Weiss D, Pathela P, Harrison C, Rakeman J, Langley G et al.. 2020. Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.. MMWR Morb Mortal Wkly Rep. 69(28):918-922.

SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.

Westblade LF, Brar G, Pinheiro LC, Paidoussis D, Rajan M, Martin P, Goyal P, Sepulveda JL, Zhang L, George G et al.. 2020. SARS-CoV-2 Viral Load Predicts Mortality in Patients with and without Cancer Who Are Hospitalized with COVID-19.. Cancer Cell. 38(5):661-671.e2.

Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.

Huang Z, Ning B, Yang HS, Youngquist BM, Niu A, Lyon CJ, Beddingfield BJ, Fears AC, Monk CH, Murrell AE et al.. 2021. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.. J Clin Invest. 131(7)

Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.

Alpert T, Brito AF, Lasek-Nesselquist E, Rothman J, Valesano AL, MacKay MJ, Petrone ME, Breban MI, Watkins AE, Vogels CBF et al.. 2021. Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States.. Cell. 184(10):2595-2604.e13.

Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.

Craney A, Petrik D, Suhku A, Qiu Y, Racine-Brzostek S, Rennert H, Piscatelli H, Rathnaiah G, Hangman A, Carrie M et al.. 2021. Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs.. Microbiol Spectr. 9(1):e0008321.

Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States.

Alpert T, Brito AF, Lasek-Nesselquist E, Rothman J, Valesano AL, MacKay MJ, Petrone ME, Breban MI, Watkins AE, Vogels CBF et al.. 2021. Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States.. medRxiv.

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.

Satlin MJ, Goyal P, Magleby R, Maldarelli GA, Pham K, Kondo M, Schenck EJ, Rennert H, Westblade LF, Choi JJ et al.. 2020. Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.. PLoS One. 15(7):e0236778.